MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fcvm.2026.1840979

Медицинская библиотека · Frontiers in cardiovascular medicine · 2026

Clinical outcomes of Impella 5+ in acute myocardial infarction-related cardiogenic shock: a retrospective single-center study.

Maj Giulia, Piermartiri Alberto, Querio Serena, Bandini Marta, Lombardi Marco, Elia Edoardo, Penpa Serena, Mazzucco Riccardo, Pappalardo Federico, Cavozza Corrado, Gallo Alina, Audo Andrea, Patti Giuseppe, Secco Gioel Gabrio

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Temporary mechanical circulatory support (t-MCS) with Impella CP has recently attracted considerable interest as a therapeutic option for cardiogenic shock (CS) complicating acute myocardial infarction (AMI). In contrast, evidence regarding the use of the larger Impella 5+ (5.0/5.5) in this clinical setting remains limited. This single-centre retrospective study aimed to evaluate the clinical impact of Impella 5+ in patients with AMI-related cardiogenic shock (AMI-CS).

METHODS AND

RESULTS

Between January 2022 and August 2024, 28 patients referred for AMI-CS were treated with Impella 5+. 11 patients were classified as SCAI C, 11 as SCAI D and 6 as SCAI E. On admission, median inotropic score was 10.5 and median left ventricular ejection fraction was 17.5%. 12 patients required concomitant ECMO support (ECPella). 19 patients were escalated from IABPM to Impella 5+. The median length of support was 8 days, 2 patients (7%) received the support for more than 30 days. 1 patient experienced a major bleeding complication. The overall survival during index hospitalization was 79%: 3 patients were bridged to a durable left ventricular assist device (LVAD) and 2 received heart transplantation (HTx).

CONCLUSIONS

Impella 5+ appears to be a safe and effective option in AMI-CS, associated with improved survival and a relatively low incidence of vascular and non-vascular complications. Its advanced features broaden the therapeutic potential of microaxial flow pumps in this high-risk setting.

Для цитирования: Maj Giulia, Piermartiri Alberto, Querio Serena, Bandini Marta, Lombardi Marco, Elia Edoardo, Penpa Serena, Mazzucco Riccardo, Pappalardo Federico, Cavozza Corrado, Gallo Alina, Audo Andrea, Patti Giuseppe, Secco Gioel Gabrio. Clinical outcomes of Impella 5+ in acute myocardial infarction-related cardiogenic shock: a retrospective single-center study.. Frontiers in cardiovascular medicine. 2026. DOI: 10.3389/fcvm.2026.1840979.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.